FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury

In both fatal cases, patients developed markedly elevated liver enzymes and required hospitalization within two months of Elevidys infusion. An additional serious, non-fatal case of acute liver injury ...
Fierce Pharma

FDA restricts Sarepta's gene therapy Elevidys after Duchenne patient deaths

The updated label now includes a boxed warning and a new “limitation of use" in addition to the removal of the prior ...
Coingape

Balancer Hack Update: Exploiter Begins Selling Stolen Tokens After Protocol Recovered $4.1M

The Balancer hack attacker has moved 6,999 ETH as recovery efforts continue, with $4.1M reclaimed and StakeWise's retrieval ...

Sarepta stock rises after FDA adds safety warning but maintains approval

Investing.com -- Sarepta Therapeutics (NASDAQ:SRPT) stock rose 7% after the U.S. Food and Drug Administration approved new labeling for its gene therapy Elevidys that includes a Boxed Warning and ...
Vanguard

The consequential tenure of AGF Fagbemi

By EMMANUEL ONWUBIKO Around January 22, 2022, Mr. Earl Timothy, a thinker penned a piece on the re-defination of leadership ...

SOF IMO Syllabus for Class 1 to 12, Check Level 1 & 2 SOF IMO Syllabus and Exam Pattern

Check the latest SOF IMO 2025 syllabus and exam pattern for Classes 1 to 12. Know section-wise topics, marking scheme, and ...
Le Lézard

Sarepta Announces FDA's Approval of Updated ELEVIDYS Prescribing Information

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced an update to the prescribing information for ELEVIDYS (delandistrogene moxeparvovec-rokl), the ...